Care Coordination System for Dementia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Care4AD treatment for dementia?
Is the Care Coordination System for Dementia safe for humans?
How is the Care4AD system treatment different from other dementia treatments?
The Care4AD system is unique because it focuses on improving communication and coordination among care networks for people with dementia, using a digital platform to support caregivers and healthcare providers. This approach emphasizes integrating various health services and community resources to provide comprehensive, patient-centered care, which is different from traditional treatments that may not address these aspects.410111213
What is the purpose of this trial?
Dementia, a chronic disease of aging, is characterized by progressive cognitive decline that interferes with independent functioning. The medical, psychological, social and functional sequelae of dementia cause great stress to patients, their caregivers, and their family. The investigator proposes to examine effectivness of a home-based care coordination and management device, called Care4AD to help caregivers effectively coordinate, manage, and improve dementia care.
Eligibility Criteria
This trial is for people over 65 with mild or moderate Alzheimer's Disease who live at home with a caregiver. Participants must be able to walk and communicate in English or Spanish. It's not suitable for those with severe dementia, major medical/psychiatric issues, significant hearing/vision loss, living in nursing homes, receiving hospice care, or without an available caregiver.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Care4AD device with activated reminders for the intervention group and deactivated reminders for the control group
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Care4AD system
Find a Clinic Near You
Who Is Running the Clinical Trial?
Bijan Najafi, PhD
Lead Sponsor
BioSensics
Industry Sponsor
BioSensics LLC
Collaborator